Objective: The objective of this study is to define novel biomarkers for Prostate Cancer (PCa) via in silico analysis that takes PCa-specific miRNAs, finds their combinatorial target genes (potential ceRNAs), selects ones containing Transcribed Ultra Conserved Region (T-UCR) among them and potentiates their relevance with PCa. Methods: Thirty-four miRNAs of which clinical relevances with PCa were proved experimentally were exported via miRWalk database.Using the ComiR database, 859 genes targeted by these 34 miRNAs simultaneously were identified. Genes with ComiR score above 0.911 were taken into account. Genes containing T-UCR and showing potential ceRNA activity were extracted. Among PCa-associated ceRNAs including T-UCR, we identified genes with significant expression differences between PCa and normal prostate tissue using the GEPIA database. The statistical evaluation of the association of NFAT5 and PTBP2 genes with PCa was performed by Spearman correlation test in GEPIA database.
INTRODUCTION
PCa is now considered one of the most important health problems that the male population is exposed to. In Europe, prostate cancer is seen in 214 out of 1000 men and it is the most frequent type of solid cancer in men. Prostate cancer is followed by lung and colorectal cancers, respectively. PCa is also the second most widespread reason for cancer deaths in men 1 . miRNAs are RNAs that have a length of 18-22 nucleotides, do not encode proteins and are naturally produced by cells. One of the most current and known RNA-induced silencing mechanisms is silencing by miRNAs. Regulation of gene expression through miRNAs is a new research topic that is widely found in today's science community. Until today, many miRNA studies have been realized. In these studies, even though the mechanisms of regulation of genes targeted by miRNAs have been explored or miRNA expression levels have been examined in certain diseases, information about the regulation of miRNA expression is still insufficient 2 . ceRNAs are RNA transcripts that carry common miRNA target regions by themselves and can communicate with each other by pulling miRNAs onto themselves. Reductions or deletions of transcription levels of genes carrying a common miRNA target region will cause miRNAs targeting these regions to be released and to seek new targets. These miRNAs will suppress transcriptionally their activities by selecting the ceRNAs bearing the same miRNA binding region as their new target. The increase in transcription levels of these mRNAs, which exhibit an opposite effect with ceRNA activity, will automatically reduce the effect of miRNAs on their previous targets by drawing common miRNAs on themselves. With this mechanism in mind, specific databases can be used to detect genes that may exhibit possible ceRNA activity, as well as experimental activities 3 . Ultra Conserved Regions (UCRs), a class of genetic elements with almost-precise evolutionary conservation among various mammalian genomes, are primarily defined by comparing the human, rat, and mouse genomes. Almost 93% of UCRs can be transcribed in many normal human tissues and RNA transcribed from UCRs is regarded as T-UCR. TUCRs function as a type of special long noncoding RNAs (lncRNAs) but have exceptional features of lncRNAs. T-UCRs may take a crucial function in development of diseases, like cancer 4 . The onset of total prostate specific antigen (total PSA) testing in blood has transformed the detection and handling of men with PCa. PSA is a powerful prognostic indicator for long-term risk of medically relevant cancer. Yet, there is a requirement for novel biomarkers that help clinical decision management about biopsy and primary medication 5 . So, the aim of this study is to define novel biomarkers for PCa via in silico analysis that takes PCa-specific miRNAs, finds their combinatorial target genes (potential ceRNAs), selects ones containing T-UCR among them and potentiates their relevance with PCa by statistical correlation methods.
METHODS

Selection of miRNAs taking role in PCa pathogenesis
Thirty-four miRNAs of which clinical relevances with PCa were proved experimentally were exported via miRWalk database. miRWalk database presents predicted and validated data on miRNA-target interaction. That type of data source empowers scientists to validate novel targets of miRNAs both on 3′-UTR and on the other parts of all known genes. The 'Validated Target module' used in this study is updated every month 6 .
Analysis of PCa-specific miRNA-mediated ceRNAs
Using the ComiR database, 859 genes targeted by these 34 miRNAs simultaneously were identified. We took into account genes with ComiR score above 0.911. ComiR is an online application for combinatorial microRNA (miRNA) target prediction. Upon uploading of a messenger RNA (mRNA) in human, mouse, fly or worm genomes, ComiR determines the potency of being targeted by a group of miRNAs. In computing the regulative potency of an mRNA from a group of miRNAs, ComiR utilizes userprovided miRNA expression levels in a combinatorial manner with suitable machine learning methods and thermodynamic modeling to perform more precise predictions. ComiR gives the possibility of being a functional target of a group of miRNAs, depending on the corresponding miRNA expression levels, for each gene 7 . We anticipate that RNA transcripts of these genes show potential ceRNA activity for these miRNAs and that they can regulate their regulation through miRNA-sponging mechanism. Matching of PCa-associated ceRNA with genes including T-UCR Bejerano et al. detected the UCRs in the human genome. Genes containing these regions have been classified as upstream, within (exonic) and downstream according to where it is located in the gene 8 . We also identified genes containing T-UCR in their exonic regions and extracted ones showing potential ceRNA activity in our previous analysis among them.
Analysis of PCa-associated ceRNAs including T-UCR with respect to differential gene expression between PCa and normal prostate tissues
Among PCa-associated ceRNAs including T-UCR, we identified genes with significant expression differences between PCa and normal prostate tissue using the GEPIA database 9 .
Correlation analysis of NFAT5 and PTBP2 genes in PCa
The statistical evaluation of the association of NFAT5 and PTBP2 genes with PCa was performed by Pearson correlation test in GEPIA database. RESULTS A list of 34 miRNAs experimentally associated with PCa using miRWalk database is given in Table I . (Table II) . We identified genes with significant expression differences between PCa and normal prostate tissues among PCa-associated ceRNAs including T-UCR. According to this analysis, NFAT5 and PTBP2 genes were significantly less expressed in PCa than in normal prostate tissue while the others didn't show any significant differential expression pattern (Table III) . A statistical evaluation of the association of NFAT5 and PTBP2 genes with PCa was performed via the GEPIA database. NFAT5 and PTBP2 gene pair were found to be significantly associated with PCa according to the Spearman correlation analysis ( Figure 1 ). (p=0.000012; R=0.72). DISCUSSION PSA is one of the most widely used tumor markers and strongly correlates with the risk of harboring PCa. However, there is a need for novel biomarkers that aid clinical decision making about biopsy and initial treatment 5, 10 . Therefore, the purpose of this study is to present novel biomarkers for PCa via in silico analysis that takes PCa-specific miRNAs, finds their combinatorial target genes (potential ceRNAs), selects ones containing T-UCR among them and potentiates their relevance with PCa by statistical correlation methods. In this study, 34 miRNAs experimentally associated with PCa was extracted via miRWalk database (Table I) . Among 859 genes targeted by these 34 miRNAs simultaneously, genes having ComiR equal abundance score above 0.911 were listed in a decreasing order. From the list of genes containing T-UCR according to the study of Bejerano et al., genes containing T-UCR in their exonic regions were identified 8 . Then, we extracted ones showing potential ceRNA activity in our previous analysis among them (Table II) . Then, we selected genes with significant expression differences between PCa and normal prostate tissues among PCaassociated ceRNAs including T-UCR. According to this analysis, NFAT5 and PTBP2 genes were significantly less expressed in PCa than in normal prostate tissue while the others didn't show any significant differential expression pattern. Also, NFAT5 and PTBP2 gene pair were found to be significantly associated with PCa according to the Spearman correlation analysis. None of NFAT5 and PTBP2 genes have been experimentally associated with prostate cancer before. Our study is the unique study to link these two genes with prostatic cancers. If we examine the role of these two genes in other types of cancer, there are contradictory results for both of them. NFAT5 is a member of NFAT protein family having a DNA binding domain with structural similarity to the Rel-homology-region of NF-κB. Apart from NFAT1-4 proteins are moderated by calcineurin, NFAT5 is modulated by osmotic pressure at nuclear localization, transcriptional and expression levels. Upon activation, NFAT5 triggers target genes' transcription by binding to tonicity enhancer elements (TonE) in regulatory domains, like sodium-myoinositol transporter 1, aldose reductase, betaine GABA transporter, the neuropathy target esterase and taurine transporter which provide cells to stimulate cell survival in hypertonic conditions 11 . NFAT5 shows its oncogenic role in via different pathways in renal cell carcinoma, breast cancer, lung adenocarcinoma and colon cancer. NFAT5-mediated expression of S100A4 stimulates migration and proliferation of renal carcinoma cells 12 . Also, NFAT5/STAT3 interaction moderates synergism of high salt with IL-17 towards induction of VEGF-A expression in breast cancer cells 13 . Moreover, NFAT5 stimulates migration and proliferation of lung adenocarcinoma cells in part via modulating AQP5 expression 14 . Furthermore, Src kinase pathway is included in NFAT5-mediated S100A4 induction by hyperosmotic stress in colon cancer cells 15 22 . In the present study, NFAT5 and PTBP2 genes were associated with PCa as unique in the literature and our in silico analysis results foresee that they may potentially have tumor suppressive role in PCa. The fact that there are contradictory results on their roles in different cancer types may make our study results preliminary for the next in vitro and in vivo studies realized to find out exact roles NFAT5 and PTBP2 genes in PCa progression.
CONCLUSION
All in all, this is the study associating NFAT5 and PTBP2 genes with PCa for the fisrt time and giving them tumor suppressive potential for PCa. Still, larger and more comprehensive studies are needed on this issue. 
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